http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107480421-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5fdd9da231b319cb1307a50593392b9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00 |
| filingDate | 2017-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bdf416e4287bc159062e4a2a4ce59b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b1e032f32c6545c6a11ffb228510e5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_395ee13d35ab80c6f0ec60a096d4267f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaf9571bb5077d805e296e1ae44c648c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56807d71c4ef0769b10e2529ddd85688 |
| publicationDate | 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107480421-A |
| titleOfInvention | Familial aggregation cerebrovascular disease Asia accurate prevention and control |
| abstract | The present invention is familial aggregation cerebrovascular disease Asia accurate prevention and control, by comparing cerebral thrombus levy person I and II relatives' illness rate, cerebral hemorrhage levy person I and II relatives' illness rate compares, cerebral thrombus levy person first degree relative cerebral thrombus segregation ratio is estimated, cerebral hemorrhage levy person first degree relative cerebral hemorrhage segregation ratio is estimated, cerebral thrombus one-level second degree relative palsy heredity grade is estimated, the estimation of cerebral hemorrhage one-level second degree relative palsy heredity grade, and the gene expression of familial aggregation patients with cerebrovascular disease has obvious Familial Occurrence.According to the conditions of patients of different symptoms, enteric coated aspirin is had differences in the application for the treatment of familial aggregation cerebral thrombus and cerebral hemorrhage, appropriate increase and decrease effective dose, cerebral thrombus recurrence, cerebral hemorrhage and hemorrhage of digestive tract etc. can effectively be reduced, diagnostic criteria is formulated according to familial aggregation cerebral thrombus and the genetic background of familial aggregation cerebral hemorrhage, and formulates the sub- accurate preventative strategies of familial aggregation cerebrovascular disease. |
| priorityDate | 2017-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.